Jove
Visualize
Contact Us

Related Experiment Videos

Anticancer drug, ara-C, release from pHEMA hydrogels

R M Trigo1, M D Blanco, J M Teijón

  • 1Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense de Madrid, Spain.

Biomaterials
|November 1, 1994
PubMed
Summary

This study shows how the anticancer drug cytarabine (ara-C) is released from a poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogel. Release rates depend on temperature, drug load, and hydrogel thickness, allowing for diffusion coefficient determination.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying imprints of externally derived dust and halogens in the sedimentary record of an Iberian alpine lake for the past ∼13,500 years - Lake Peixão, Serra da Estrela (Central Portugal).

The Science of the total environment·2023
Same author

The influence of soil dry-out on the record-breaking hot 2013/2014 summer in Southeast Brazil.

Scientific reports·2022
Same author

Twenty-first century droughts have not increasingly exacerbated fire season severity in the Brazilian Amazon.

Scientific reports·2021
Same author

Pediatric surgical activity during the SARS-CoV-2 pandemic: experience at a tertiary hospital.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2021
Same author

Thyroid surgery in pediatric patients: causes and results.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2021
Same author

Saharan dust intrusions in the Iberian Peninsula: Predominant synoptic conditions.

The Science of the total environment·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Drug Delivery Systems

Background:

  • Polymeric hydrogels are widely explored for controlled drug delivery applications.
  • Cytarabine (ara-C) is a crucial chemotherapeutic agent for treating various cancers.
  • Understanding drug release kinetics from hydrogel matrices is essential for optimizing therapeutic efficacy.

Purpose of the Study:

  • To investigate the controlled release of cytarabine (ara-C) from a poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogel matrix.
  • To analyze the swelling behavior of pHEMA hydrogel discs as a function of temperature and thickness.
  • To determine the influence of temperature, initial drug load, and disc thickness on ara-C release kinetics.

Main Methods:

  • Preparation of lightly cross-linked pHEMA hydrogel discs.

Related Experiment Videos

  • Analysis of hydrogel swelling in water at varying temperatures and disc thicknesses.
  • In vitro release studies of cytarabine (ara-C) from pHEMA discs under different conditions.
  • Mathematical modeling to determine diffusion coefficients for water uptake and drug release.

    • Main Results:

    • Hydrogel swelling was found to be linear with the square root of time for initial periods.
    • Cytarabine (ara-C) release kinetics also exhibited a linear relationship with the square root of time initially.
    • Release rates were significantly affected by temperature, initial drug concentration, and hydrogel thickness.
    • Diffusion coefficients for water ingress and ara-C egress were successfully determined.

    Conclusions:

    • The pHEMA hydrogel system demonstrates potential for controlled release of cytarabine (ara-C).
    • The study provides valuable insights into the diffusion-controlled release mechanism of ara-C from pHEMA.
    • The findings enable the optimization of hydrogel-based drug delivery systems for anticancer therapies.